Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

New AIM admission: Northcoders set for training roll out

New AIM admission: GENinCode awaiting FDA approval

New AIM admission: Zenova’s fire retardant IP is not a flame proof investment

New standard listing: Sivota seeking Israeli technology deal

New AIM admission: Microlise Group

New AIM admission: Lords Group Trading

New AIM: Admission Revolution Beauty

New AIM admission: Bradda Head

New AIM admission: Poolbeg Pharma

All Active Asset bid approach for Audioboom

New standard listing: Acceler8 Ventures

New AIM admission: Forward Partners Group

New premium listing: Seraphine

New AIM admission: Orcadian Energy

New AIM admission: Lendinvest

Good Energy reiterates indicative bid rejection

Healthcare M&A prospects

Potential financials and property bids

Upgrades at Hotel Chocolat

Tip: Prosperous niche drugs strategy

Tip update: AdEPT Technology

New AIM admission: LungLife AI

New AIM admission: CMO Group

New Aquis admission: Helium Ventures

New standard listing: Wise

New AIM Admission: Saietta Group

Tip update: Lok’nStore

Three days left for Forward Partners PrimaryBid offer

Purplebricks likely to set out strategy

New Aquis admission: Voyager Life

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020